Clinical Trial Update: The Efficacy and Safety Evaluation of 5G Tele-PCI Using R-OneTM [NA]

View source ↗

Summary

This clinical trial update covers the ongoing evaluation of the 5G Tele-PCI robotic system (R-One) for coronary artery disease in patients undergoing percutaneo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Cathbot (Shanghai) Robot Co., Ltd | Conditions: Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) | NA | Status: ENROLLING_BY_INVITATION